magazine 12 Sep 2019
Download PDF Page flip version
Brexit fears and a weak pound have made large chunks of the London market look very cheap to foreign buyers, leading to a new wave of takeover deals. Shares magazine examines the market and highlights five potential takeover targets.
Also this week: a rush of PPI claims hurts shares in Lloyds and other banks; and Woodford may gauge demand ahead of suspension lifting for investors wanting to sell out of its income fund.
Shares analyses Next’s business model, it explains how certain funds are awarded five-star ratings, and it weighs up the difference between ETFs and traditional tracker funds.
You can also read about AstraZeneca, Centrica, EasyJet, Synthomer and more
Mark from Edinburgh is taking higher risks in an effort to hit a number of goals
A weak currency and cheap valuations make the UK a happy hunting ground for deal-makers
Can the likes of International Consolidated Airlines and Ryanair win back the market’s favour?
Analysts consider the potential price tag for mooted asset sales and whether it could be a takeover target
The administrator of the troubled income fund is understood to be weighing up a 14 day pre-dealing period
Investors are now worried about the impact PPI claims will have on dividends
The FTSE 100 stock is one of our favourite companies on the London Stock Exchange
Independent ratings systems are a vital tool in your armoury when it comes to assessing funds
Trusts using debt to supercharge returns can incur problems in a market downturn
New research shows why you shouldn’t ignore an earnings alert from something in your portfolio
His actions have put the spotlight back on something called ‘the Triffin dilemma’
Dropping RPI inflation could have a negative effect for pensioners and investors
Contrarian investment trust targets beaten down stocks with the potential to rebound
The company should benefit from capacity expansion and a deal to boost its position in the US and Europe
Shares in the pharma business hit by reports of potential price controls on US drugs
Half-year results were very disappointing so time to sell the shares
A reader approaching retirement asks if they should bring forward their de-risking plans
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
